Merck COVID-19

• Merck’s antiviral COVID-19 pill approved by U.S. FDA for at-home use

  Merck's drug, molnupiravir, developed with Ridgeback Biotherapeutics, was shown to reduce COVID-19 hospitalizations and deaths by around 30 per cent.

  World

  Dec 23, 2021
  
• Merck’s COVID-19 pill reduces hospitalization, death risk by 30%, company says

  The company said the data on the drug molnupiravir had been submitted to the U.S. Food and Drug Administration ahead of a meeting of its expert advisers on Tuesday.

  Health

  Nov 26, 2021
  
• Advertisement
• COVID-19 antiviral pill approved in U.K. still being reviewed by Health Canada

  Merck has been supplying data to Health Canada on a rolling basis since August, when the product was still undergoing clinical trials.

  Canada

  Nov 4, 2021
• Advertisement
• Merck asks U.S. FDA for emergency stamp for COVID-19 tablet

  An authorization from the U.S. Food and Drug Administration could help change clinical management of COVID-19 as the pill can be taken at home.

  World

  Oct 11, 2021